Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration

Abstract

Introduction: Vascular endothelial growth factor A (VEGF-A) is a chemokine that induces proliferation and migration of vascular endothelial cells and is essential for both physiological and pathological angiogenesis. It is known for its high heritability (> 60%) and involvement in most common morbidities, which makes it a potentially interesting biomarker. Large GWAS studies have already assessed polymorphisms related to VEGF-A. However, no previous research has provided epigenome-wide insight in regulation of VEGF-A. Methods: VEGF-A concentrations of healthy participants from the STANISLAS Family Study (n = 201) were comprehensively assessed for association with DNA methylation. Genome-wide DNA methylation profiles were determined in whole blood DNA using the 450K Infinium BeadChip Array (Illumina). VEGF-A concentration in PBMC extracts was detected using a high-sensitivity multiplex Cytokine Array (Randox Laboratories, UK). Results: Epigenome-wide association analysis identified 41 methylation sites significantly associated with VEGF-A concentrations derived from PBMC extracts. Twenty CpG sites within 13 chromosomes reached Holm-Bonferroni significance. Significant values ranged from P = 1.08 × 10 −7 to P = 5.64 × 10 −15. Conclusion: This study exposed twenty significant CpG sites linking DNA methylation to VEGF-A concentration. Methylation detected in promoter regions, such as TPX2 and HAS-1, could explain previously reported associations with the VEGFA gene. Methylation may also help in the understanding of the regulatory mechanisms of other genes located in the vicinity of detected CpG sites.

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer

“…However, epigenetic modifications may diminish VEGF expression. Vesna and colleagues found twenty significant CpG sites in promoter regions, suggesting that the concentration of VEGF-A can be regulated by DNA methylation ( 77 ). Based on The Cancer Genome Atlas (TCGA) databases, Zhou and colleagues discovered that overexpression of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) was related to cancer progression and poor survival of patients.…”

Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets

“…Interestingly, 20 methylation sites have been significantly associated with VEGFA levels in PBMCs from healthy individuals. 38 Therefore, methylation levels at these sites could be evaluated in affected patients, in order to identify potential alterations that could serve as therapeutical target to influence VEGFA expression and activity. Furthermore, AMD-related epigenetic marks and events characterizing molecular factors involved in Angiopoietin/Tie-2 pathway could be investigated.…”

Long reads capture simultaneous enhancer–promoter methylation status for cell-type deconvolution

“…The accumulation of high-throughput genome-wide methylation data has enabled the analysis of human methylomes across distinct populations and medical cohorts via epigenome-wide association studies (EWAS) ( Gorenjak et al , 2020 ; Küpers et al , 2019 ; Chu et al , 2017 ). Such analyses have shown that predisposition to common human disease is frequently associated with specific methylation signatures in distal control regions also known as gene enhancers ( Li et al , 2013 ).…”